Related Experiment Video
Updated: Feb 3, 2026

Structure of HIV-1 Capsid Assemblies by Cryo-electron Microscopy and Iterative Helical Real-space Reconstruction
Published on: August 9, 2011
Exploring Modifications of an HIV-1 Capsid Inhibitor: Design, Synthesis, and Mechanism of Action
Jimmy P Xu1, Ashwanth C Francis2, Megan E Meuser1
1Department of Biochemistry & Molecular Biology, Drexel University College of Medicine, USA.
Researchers redeveloped the HIV-1 capsid inhibitor PF-74 by creating new compounds with improved metabolic stability. These novel molecules inhibit HIV-1 infection by binding to the capsid hexamer, offering a promising therapeutic avenue.
Area of Science:
- Virology
- Medicinal Chemistry
- Drug Discovery
Background:
- The HIV-1 capsid (CA) protein is a key target for novel antiviral therapies.
- The PF-74 compound inhibits HIV-1 by targeting an interprotomer pocket in the CA hexamer.
- PF-74 exhibits poor metabolic stability, limiting its therapeutic potential.
Purpose of the Study:
- To redevelop the PF-74 scaffold by addressing its metabolic instability.
- To create novel HIV-1 capsid inhibitors with improved drug-like properties.
Main Methods:
- Bioisosteric modification of the PF-74 scaffold.
- Field-based bioisostere identification.
- Biochemical and biological assessments of new compounds.
- Mechanism of action studies.
Main Results:
- Four new compounds were synthesized that inhibit HIV-1 infection.
- These compounds bind to the assembled HIV-1 CA hexamer.
- Modifications altered the compounds' effect on HIV-1 capsid core stability compared to PF-74.
Conclusions:
- Bioisosteric modification is a viable strategy for improving HIV-1 capsid inhibitor properties.
- The new compounds demonstrate potential as lead candidates for HIV-1 therapy.
- Further optimization is needed to enhance potency and drug-like characteristics.
More Related Videos
Related Concept Videos
SN1 Reaction: Mechanism
Firstly, the haloalkane ionizes to generate a carbocation intermediate and a halide ion. This heterolytic cleavage is highly endothermic with large activation energy. The ionization of the substrate, facilitated by a...
Depolarizing Blockers: Mechanism of Action
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
Local Anesthetics: Mechanism of Action
Local anesthetics are amphiphilic molecules consisting of a hydrophobic aromatic part linked to a hydrophilic group by an ester or amide linkage. They are weak bases and are usually available as salts, which increases their solubility and stability. Once administered, LAs exist in the body either...
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Antihypertensive Drugs: Action of β1 Blockers
Preparation of 1° Amines: Azide Synthesis
Azide ions act as good nucleophiles and react with unhindered alkyl halides to form alkyl azides. Alkyl azides do not participate in further nucleophilic substitution reactions, thereby eliminating the chances of polyalkylated products. Alkyl azides are reduced by hydride-based reducing agents, like lithium aluminum...

